← Back
Data updated: Sep 20, 2026
KNOA PHARMA
Big Pharma Pharmaceuticals
KNOA PHARMA is a major pharmaceutical company with 6 FDA-approved products.
1987
Since
6
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
3 Small Molecules
KNOA PHARMA's Key Drugs
KNOA PHARMA's core commercial portfolio centers on ZURNAI (AUTOINJECTOR) — its most strategically important drugs approved in the last 15 years.
KNOA PHARMA's Recent FDA Approvals
New NDA/BLA approvals for KNOA PHARMA over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
KNOA PHARMA's Therapeutic Areas
Disease areas where KNOA PHARMA has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
KNOA PHARMA Pipeline Snapshot
Active clinical trials for KNOA PHARMA across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • ZURNAI (AUTOINJECTOR) leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (1)
Discontinued (1)
Company Info
- First Approval
- 1987-05-29
- Latest
- 2026-06-18
- Applications
- 6